2024 Regular Session
SB224   by Senator Robert "Bob" Owen      

PHARMACEUTICALS:  Provides relative to opioid alternatives. (8/1/24) (EN NO IMPACT See Note)

Current Status:  Signed by the Governor - Act 320


Skip Navigation Links
TextExpand Text
AmendmentsExpand Amendments
DigestsExpand Digests
NotesExpand Notes
VotesExpand Votes
AuthorsExpand Authors

 Date   ChamberJournal
Page
Action sort history by ascending dates
05/28S  Effective date 8/1/2024.
05/28S  Signed by the Governor. Becomes Act No. 320.
05/28S84  Sent to the Governor by the Secretary of the Senate on 5/23/2024.
05/23H1  Signed by the Speaker of the House.
05/23S102  Enrolled. Signed by the President of the Senate.
05/22S39  Received from the House without amendments.
05/22H54  Read third time by title, roll called on final passage, yeas 96, nays 0. Finally passed, ordered to the Senate.
05/21H  Scheduled for floor debate on 05/22/2024.
05/21H8  Read by title, passed to 3rd reading.
05/20H15  Reported without Legislative Bureau amendments.
05/15H45  Reported favorably (11-0). Referred to the Legislative Bureau.
05/07H5  Read by title, under the rules, referred to the Committee on Health and Welfare.
05/06H2  Received in the House from the Senate, read by title, lies over under the rules.
05/01S25  Read by title, passed by a vote of 39 yeas and 0 nays, and sent to the House. Motion to reconsider tabled.
04/30S38  Read by title and passed to third reading and final passage.
04/30S37  Rules suspended. Recalled from Committee.
04/29S13  Read by title. Committee amendments read and adopted; ordered engrossed and recommitted to the Committee on Finance.
04/24S8  Reported with amendments.
03/11S23  Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Health and Welfare.
03/01S  Prefiled and under the rules provisionally referred to the Committee on Health and Welfare.